Among these, in relation to HER2-positive tumors, it has been shown that having a family history of cancer, higher breast density, and obesity (body mass index >30) increases the odds of having this particular subtype (51). The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.